New therapeutic perspectives in the treatment of uveal melanoma: A systematic review

MD Toro, L Gozzo, L Tracia, M Cicciù, F Drago… - Biomedicines, 2021 - mdpi.com
Uveal melanoma (UM) is a rare disease, but the most common primary intraocular cancer,
mostly localized in the choroid. Currently, the first-line treatment options for UM are radiation …

Safety of intravitreal chemotherapy in the management of retinoblastoma: A systematic review of the literature

G Lavasidis, M Strongylis, A Tzamalis… - Critical Reviews in …, 2024 - Elsevier
Intravitreal chemotherapy is used as a salvage therapy for retinoblastoma with persistent or
recurrent vitreous seeding after primary treatment. To assess the safety of this technique, we …

Safety and efficacy of intravitreal chemotherapy (melphalan) to treat vitreous seeds in retinoblastoma

YA Yousef, M Al Jboor, M Mohammad… - Frontiers in …, 2021 - frontiersin.org
Background: Active vitreous seeds in eyes with retinoblastoma (Rb) adversely affects the
treatment outcome. This study aimed to investigate the safety and efficacy of intravitreal …

Retinoblastoma: An update on genetic origin, classification, conventional to next-generation treatment strategies

A Pareek, D Kumar, A Pareek, MM Gupta, P Jeandet… - Heliyon, 2024 - cell.com
The most prevalent paediatric vision-threatening medical condition, retinoblastoma (RB),
has been a global concern for a long time. Several conventional therapies, such as systemic …

A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma

M Mohammad, R Shehada… - European Journal …, 2023 - journals.sagepub.com
Aim To compare the risk and pattern of High-Risk Pathologic Features (HRPF) in
retinoblastoma between primary and secondary enucleation. Methods A retrospective …

Clinicodemographic profile, management, and treatment outcomes in advanced retinoblastoma at a tertiary care center in North India

SV Kumar, V Kumar, A Sati, SK Mishra… - Indian Journal of …, 2024 - journals.lww.com
Purpose: The study was undertaken to look into the clinicodemographic profile,
management, and clinical outcomes of advanced retinoblastoma at a tertiary care center …

[HTML][HTML] Visual Prognosis in Retinoblastoma Patients with Multimodality Treatments.: Visual Prognosis in Retinoblastoma Patients

R Chokchaitanasin, N Asawaworarit, W Dieosuthichat… - AJO International, 2024 - Elsevier
Purpose: This study evaluates factors associated with globe preservation and long-term
visual outcomes according to clinical characteristics and treatment modalities in intraocular …

[PDF][PDF] New therapeutic perspectives in the treatment of uveal melanoma: a systematic review. Biomedicines 2021; 9: 1311

MD Toro, L Gozzo, L Tracia, M Cicciù, F Drago… - 2021 - scholar.archive.org
Uveal melanoma (UM) is a rare disease, but the most common primary intraocular cancer,
mostly localized in the choroid. Currently, the first-line treatment options for UM are radiation …

Clinical outcomes of Group D Retinoblastoma at a tertiary care hospital in Pakistan

KMAA Javed, U Vayani, A Javed, MH Chatni - 2023 - researchsquare.com
Purpose To retrospectively analyse globe salvage rates in group D retinoblastoma (RB) with
currently available treatment options in Pakistan over a period of nine years. Methods A …